OIG Gets Mixed Results On Question Of Medicaid Pharmacy Reimbursement
Executive Summary
The latest analysis of Medicaid's reimbursement for multiple-source drugs finds that with an average manufacturer price-based federal upper limit, pharmacies could be reimbursed more than they paid for the drugs overall, even as a number of drugs are under-reimbursed. But retail pharmacies see the report and others like it as missing the bigger picture